Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome
Year: 2005
Type: article
Study design: Clinical Trial
Source: Human Reproduction
Institutions: Stanford Medicine, Stanford University
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2105243339
